Previous Article | Next Article ![]()
Infection and Immunity, November 2003, p. 6624-6626, Vol. 71, No. 11
0019-9567/03/$08.00+0 DOI: 10.1128/IAI.71.11.6624-6626.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Max von Pettenkofer Institute for Hygiene and Medical Microbiology, Ludwig Maximillian University Munich, D-80336 Munich,1 Department of Microbiology, Technical University Munich, D-85350 Freising, Germany2
Received 5 May 2003/ Returned for modification 16 July 2003/ Accepted 7 August 2003
|
|
|---|
|
|
|---|
The genus Yersinia comprises three human-pathogenic species: Y. pestis, the "plague bacillus," and the enteropathogenic Y. enterocolitica and Y. pseudotuberculosis. The Y. enterocolitica strains of biogroup IB are highly pathogenic for mice and thus are commonly used (in particular serotype O8 strains WA-314 and 8081) for the mouse intestinal infection model. After oral inoculation of mice, the pathogen invades the Peyer's patches of the small intestine and subsequently disseminates into spleen, liver, and lungs (2). The luxI-luxR homologues of Y. enterocolitica 10460 (serotype 1), yenI-yenR, have been cloned and sequenced (11). At the level of amino acids, YenI of this strain is 98.6% homologous to YenI of Y. enterocolitica 8081(http://www.sanger.ac.uk/Projects/Y_enterocolitica/). It wasshown that YenI directs the synthesis of N-hexanoyl-L-homoserine lactone (HHL) and N-(3-oxohexanoyl)-L-homoserine lactone (OHHL). Mutation in yenI abolished HHL and OHHL synthesis but did not affect the production or secretion of Yersinia outer proteins (Yops) encoded by the virulence plasmid pYV of Y. enterocolitica serotype O9 (nonvirulent for mice). Since no studies have been performed with Yersinia to elucidate the role of AHL in virulence, we initiated in vitro and in vivo quorum-sensing studies with the well-characterized, mouse-virulent Y. enterocolitica WA-314 and 8081 (serotype O8, biotype 1B), carrying the virulence plasmid pYVO8 (5). Previously, a report was published on an E. coli AHL biosensor strain which allows the detection of AHLs in sputum samples of cystic fibrosis patients colonized by Pseudomonas aeruginosa and Burkholderia cepacia (7). From these results we were encouraged to apply the same techniques for detection of AHLs produced by the mouse-virulent Y. enterocolitica strain WA-314 during growth in nutrient broth and during experimental infection of mice. To determine if the route of infection influences the distribution of AHLs within the mouse body, the animals were infected intraperitoneally (i.p.), intravenously (i.v.), or perorally (p.o.). In this report we describe for the first time the detection of OHHL from different tissues of the mouse which were infected with Y. enterocolitica. Strikingly, only OHHL, not HHL, could be detected in vitro as well as in vivo in homogenates of various mouse organs with the aid of a lux-based AHL biosensor.
AHL detection for strains WA-314 and 8081 after growth in Luria-Bertani (LB) broth. Throup et al. (11) did not study the Y. enterocolitica prototype strains of serotype O8; thus, we decided to extract homoserine lactones from in vitro-grown cultures of WA-314 and 8081 strains as described previously (4). Extraction of culture supernatant (50 ml, corresponding to 5 x 1010 bacteria) yielded 500 µl of AHL concentrate in ethyl acetate. Appropriate dilutions of the extracts were loaded on a thin-layer chromatography (TLC) plate (RP-18 F254S; 20 by 20 cm; Merck) and were run in a moisture chamber containing a mixture of 60% methanol and 40% distilled water for 6 h (9). After the plate was dried, it was overlaid with 200 ml of 0.6% soft LB agar seeded with 20 ml of a logarithmically grown culture of the lux-based AHL biosensor strain E. coli [pSB403], which is able to respond to a range of different AHLs by luciferase production (e.g., BHL, HHL, OHHL, and ODHL) (13). The incubation was carried out overnight in a moisture chamber at 30°C, and AHLs were detected via autoradiography.
Throup et al. (11) showed that Y. enterocolitica produces OHHL and HHL. Our TLC analysis confirmed the presence of OHHL of serotype O8 strains in liquid culture (Fig. 1). However, we were unable to detect HHL production in both strains, for reasons yet to be found. Strains WA-314 and 8081 might produce only small amounts of HHL, which are not detectable with our sensor strain. In addition, strain 8081 produces only about 1/10 the amount of OHHL produced by strain WA-314 (Fig. 1). The reason for this also remains unknown. We also determined the minimum number of yersiniae producing detectable AHL amounts by the TLC assay used. Performing serial dilutions and running the dilution mixtures on a TLC plate, we found that a minimum number of about 107 in vitro-grown yersiniae produced OHHL amounts sufficient to be detected. This amount is equal to less than 30 fg of OHHL (Fig. 2, lanes 4 to 9).
![]() View larger version (73K): [in a new window] |
FIG. 1. TLC analysis of in vitro-grown cultures of WA-314 and 8081. Lanes 1 and 2, synthetic HHL and OHHL, respectively; lane 3, supernatant of WA-314 corresponding to 4 x 107 bacteria; lane 4, supernatant of 8081 corresponding to 2.5 x 108 bacteria.
|
![]() View larger version (47K): [in a new window] |
FIG. 2. TLC analysis of control experiments to determine extraction efficiency in vivo. Lanes 1 to 3, intestinal lavage fluid, liver homogenate, and spleen homogenate, respectively, each seeded with supernatant of WA-314 (5 x 107 bacteria); lanes 4 to 6, supernatant of WA-314 corresponding to 5 x 107, 2.5 x 107, and 1.25 x 107 bacteria, respectively; lanes 7 to 9, synthetic OHHL at 30, 80, and 160 fg, respectively.
|
The extraction of the AHLs was performed as described previously (4), with the following modifications. Tissue homogenates were extracted twice with 50 ml of dichloromethane, and after evaporation, the residual material was dissolved in 100 µl of ethyl acetate. The total extracts were loaded in 10 10-µl steps with drying steps in between (to increase the AHL concentration) on a TLC plate as described above. In addition, the samples collected from the supernatant of each organ were also used for the AHL bioassay, with use of the same E. coli biosensor strain. Fifty microliters of the supernatant was mixed with 50 µl of a logarithmically grown biosensor strain in a white microtiter well plate and was incubated overnight at 30°C. Luminescence was detected for each well for 10 s using a highly sensitive microtiter well plate reader, MicroLumatPlus from Berthold (Bad Wildbad, Germany). All infection experiments were repeated twice with similar results.
TLC analysis (Fig. 3A) showed that OHHL but not HHL was present in only those organs from which 108 or more Y. enterocolitica bacteria were isolated (Fig. 3C). The AHL bioassay (Fig. 3B) appears to be more sensitive than the TLC analysis, as shown in Fig. 3B, bottom panel. The reason for the discrepancy between the in vitro and in vivo detection limit (107 versus 108 bacterial cells) remains to be elucidated. Several reasons are plausible: (i) the yersiniae produce less OHHL in the mouse tissue than in liquid culture, (ii) OHHL enters the circulation and thus disappears from infected tissue by subsequent excretion, and (iii) OHHL accumulates in cells of infected tissue and thus resists extraction. The regulation of AHL production in Y. enterocolitica in liquid culture medium appears to be quite similar (apart from the differing amounts) to the in vivo situation, when the pathogen is growing to microcolonies or abscesses within the tissue. The route of infection (Fig. 3A) did not influence the production and distribution of the OHHL, since the amount of OHHL isolated in vivo was similar with respect to the bacterial numbers in the respective organs and in vitro (Fig. 2 and 3C). Our data show a close correlation between the number of bacteria present in the infected organ and the amount of OHHL extracted from it (Fig. 3A and C).
![]() View larger version (29K): [in a new window] |
FIG. 3. Detection of AHLs produced in vitro and in vivo by TLC analysis (A) and by the luxR-based biosensor E. coli [pSB403] (in 100,000 arbitrary units) (B). (A) Extracts of homogenates (lanes 6 to 8) and lavage fluids (lanes 4 and 5) of organs of five BALB/c mice infected with WA-314 via the i.p. (a), i.v. (b), and p.o. (c) routes after 3 days. Lanes 1 and 2, synthetic HHL and OHHL standards, respectively; lane 3, in vitro culture of WA-314; lane 4, intestinal lavage fluid; lane 5, peritoneal lavage fluid; lanes 6 to 8, homogenates of liver, spleen, and Peyer's patches, respectively. (B) AHLs of samples shown in panel A detected by the biosensor E. coli [pSB403]. (C) Bacterial count (in log10 CFU) corresponding to the 50-ml extraction volume of samples shown in panel B.
|
In summary, by using TLC in combination with the E. coli AHL biosensor, we have demonstrated that the mouse-virulent Y. enterocolitica strains WA-314 and 8081 (serotype O8) produce OHHL but not detectable amounts of HHL, as has been reported for environmental strains (11). Since the two YenI proteins are highly homologous, it is unlikely that differences in the proteins account for the differences in AHL production. Whether quorum sensing in Y. enterocolitica plays a role in regulation of virulence genes or whether OHHL contributes directly to pathogenicity as an immunomodulator as has been reported for P. aeruginosa will be investigated with a YenI mutant (10).
We thank Gottfried Wilharm for the sequence analysis.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»